1. Home
  2. BOLD vs BOF Comparison

BOLD vs BOF Comparison

Compare BOLD & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • BOF
  • Stock Information
  • Founded
  • BOLD 2018
  • BOF 2017
  • Country
  • BOLD United States
  • BOF United States
  • Employees
  • BOLD N/A
  • BOF N/A
  • Industry
  • BOLD
  • BOF Packaged Foods
  • Sector
  • BOLD
  • BOF Consumer Staples
  • Exchange
  • BOLD Nasdaq
  • BOF Nasdaq
  • Market Cap
  • BOLD 33.4M
  • BOF 33.2M
  • IPO Year
  • BOLD 2024
  • BOF 2023
  • Fundamental
  • Price
  • BOLD $1.15
  • BOF $3.00
  • Analyst Decision
  • BOLD Buy
  • BOF
  • Analyst Count
  • BOLD 4
  • BOF 0
  • Target Price
  • BOLD $4.00
  • BOF N/A
  • AVG Volume (30 Days)
  • BOLD 85.6K
  • BOF 182.7K
  • Earning Date
  • BOLD 11-05-2025
  • BOF 11-12-2025
  • Dividend Yield
  • BOLD N/A
  • BOF N/A
  • EPS Growth
  • BOLD N/A
  • BOF N/A
  • EPS
  • BOLD N/A
  • BOF N/A
  • Revenue
  • BOLD N/A
  • BOF $11,218,127.00
  • Revenue This Year
  • BOLD N/A
  • BOF N/A
  • Revenue Next Year
  • BOLD N/A
  • BOF N/A
  • P/E Ratio
  • BOLD N/A
  • BOF N/A
  • Revenue Growth
  • BOLD N/A
  • BOF 72.85
  • 52 Week Low
  • BOLD $1.00
  • BOF $1.53
  • 52 Week High
  • BOLD $3.54
  • BOF $3.44
  • Technical
  • Relative Strength Index (RSI)
  • BOLD 39.64
  • BOF 55.60
  • Support Level
  • BOLD $1.17
  • BOF $2.55
  • Resistance Level
  • BOLD $1.18
  • BOF $3.00
  • Average True Range (ATR)
  • BOLD 0.07
  • BOF 0.25
  • MACD
  • BOLD -0.01
  • BOF -0.05
  • Stochastic Oscillator
  • BOLD 51.79
  • BOF 48.39

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About BOF BranchOut Food Inc.

Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.

Share on Social Networks: